000 | 00897 a2200265 4500 | ||
---|---|---|---|
005 | 20250517195153.0 | ||
264 | 0 | _c20181221 | |
008 | 201812s 0 0 eng d | ||
022 | _a1365-2133 | ||
024 | 7 |
_a10.1111/bjd.16065 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSanclemente, G | |
245 | 0 | 0 |
_aWhat can we learn from psoriasis pharmacogenomics research? _h[electronic resource] |
260 |
_bThe British journal of dermatology _c01 2018 |
||
300 |
_a17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aBiological Factors |
650 | 0 | 4 | _aBiological Products |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPharmacogenomic Testing |
650 | 0 | 4 | _aPsoriasis |
773 | 0 |
_tThe British journal of dermatology _gvol. 178 _gno. 1 _gp. 17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.16065 _zAvailable from publisher's website |
999 |
_c28002960 _d28002960 |